- Home
- LSB
as 11-14-2024 4:00pm EST
Stocks
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
| Founded: | 2002 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 41.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 82.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.88 - $11.20 | Next Earning Date: | 11-22-2024 |
| Revenue: | $79,415,311 | Revenue Growth: | -16.56% |
| Revenue Growth (this year): | 39.33% | Revenue Growth (next year): | 75.61% |
Latest LAKESHORE BIOPHARMA CO LTD News
LSB Breaking Stock News: Dive into LSB Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan
PR Newswire
17 days ago
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire
17 days ago
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
TipRanks
20 days ago
LakeShore Biopharma Advances with Rabies Vaccine Trial
PR Newswire
21 days ago
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
PR Newswire
21 days ago
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
PR Newswire
a month ago
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
PR Newswire
2 months ago
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
Compare LSB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LSB LAKESHORE BIOPHARMA CO LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.